Original Research
Published on 18 Mar 2024
Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2024.1285278
- 1,181 views
17 articles related to "Sars Cov 2 Spike S Protein"
Articles
Original Research
Published on 12 Sep 2022
Dok3 restrains neutrophil production of calprotectin during TLR4 sensing of SARS-CoV-2 spike protein
in Molecular Innate Immunity
Frontiers in Immunology
doi 10.3389/fimmu.2022.996637
- 2,157 views
- 4 citations
Original Research
Published on 16 Mar 2022
MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.845969
- 5,338 views
- 16 citations
Original Research
Published on 16 Mar 2022
Poxvirus MVA Expressing SARS-CoV-2 S Protein Induces Robust Immunity and Protects Rhesus Macaques From SARS-CoV-2
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.845887
- 4,900 views
- 14 citations
Original Research
Published on 09 Jun 2023
Preclinical immunogenicity and protective efficacy of a SARS-CoV-2 RBD-based vaccine produced with the thermophilic filamentous fungal expression system Thermothelomyces heterothallica C1
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1204834
- 2,243 views
Original Research
Published on 18 Oct 2023
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1163159
- 1,339 views
- 3 citations
Original Research
Published on 15 Jun 2022
Cross-Reactivity of IgG Antibodies and Virus Neutralization in mRNA-Vaccinated People Against Wild-Type SARS-CoV-2 and the Five Most Common SARS-CoV-2 Variants of Concern
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.915034
- 2,627 views
- 8 citations
Original Research
Published on 30 May 2022
Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2022.888794
- 1,969 views
- 4 citations
Original Research
Published on 03 Feb 2023
Homologous booster immunization with an inactivated vaccine induced robust antibody response in healthcare workers: A retrospective study
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2023.1099629
- 1,515 views
- 3 citations
Original Research
Published on 15 Aug 2023
Growth hormone-releasing hormone antagonist MIA-602 inhibits inflammation induced by SARS-CoV-2 spike protein and bacterial lipopolysaccharide synergism in macrophages and human peripheral blood mononuclear cells
in Inflammation
Frontiers in Immunology
doi 10.3389/fimmu.2023.1231363
- 2,931 views
Original Research
Published on 02 Feb 2024
Synthesis and evaluation of gold nanoparticles conjugated with five antigenic peptides derived from the spike protein of SARS-CoV-2 for vaccine development
in Biomedical Nanotechnology
Frontiers in Nanotechnology
doi 10.3389/fnano.2024.1335346
- 791 views
Original Research
Published on 08 Dec 2023
Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concern
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1307693
- 1,471 views
- 1 citation
Original Research
Published on 21 Sep 2021
Epitope Profiling Reveals the Critical Antigenic Determinants in SARS-CoV-2 RBD-Based Antigen
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2021.707977
- 5,963 views
- 23 citations
Original Research
Published on 04 Jun 2021
Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
in Viral Immunology
Frontiers in Immunology
doi 10.3389/fimmu.2021.691715
- 14,182 views
- 83 citations
Original Research
Published on 12 May 2023
A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike protein
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2023.1166924
- 1,531 views
- 1 citation
Brief Research Report
Published on 24 Jan 2023
Enhanced cross-recognition of SARS-CoV-2 Omicron variant by peptide vaccine-induced antibodies
in Vaccines and Molecular Therapeutics
Frontiers in Immunology
doi 10.3389/fimmu.2022.1044025
- 1,896 views
- 2 citations